1. [1] Galluzzi L, Yamazaki T, Kroemer G. Linking cellular stress responses to systemic homeostasis. Nat Rev Mol Cell Bio 2018; 19: 731-745. [DOI:10.1038/s41580-018-0068-0] [PMID]

2. [2] Habib KE, Gold PW, Chrousos GP. Behavioral methods to study anxiety in rodents. Dialogues Clin Neurosci 2017; 19: 181-191. [DOI:10.31887/DCNS.2017.19.2/wcarlezon] [PMCID]

3. [3] Gjerstad JK, Lightman SL, Spiga F. Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatility. STRESS 2018; 21: 403-416. [DOI:10.1080/10253890.2018.1470238] [PMID] [PMCID]

4. [4] Mohammad Rezaei R, Pourali-Malabad R, Shiravi A, Rashidy-Pour A, Vafaei AA. Interaction between 5-HT6 receptors and acute stress and corticosterone on fear memory reconsolidation in mice. Koomesh 2020; 22: 185-191. (Persian). [DOI:10.29252/koomesh.22.1.185]

5. [5] Choobdar S, Vafaei AA, Rashidy-Pour A, Sedaghat K. Protective role of vitamin-D on chronic stress induced-learning and memory deficits in rats. Koomesh 2019; 21: 708-715. (Persian).

6. [6] Ellenbroek BA, van der Kam EL, van der Elst MC, Cools AR. Individual differences in drug dependence in rats: the role of genetic factors and life events. Eur J Pharmacol 2005; 526: 251-258. [DOI:10.1016/j.ejphar.2005.09.032] [PMID]

7. [7] Mah L, Szabuniewicz C, Fiocco AJ. Can anxiety damage the brain? Curr Opin Psychiatry 2016; 29: 56-63. [DOI:10.1097/YCO.0000000000000223] [PMID]

8. [8] McEwen BS. Stress, sex, and neural adaptation to a changing environment: mechanisms of neuronal remodeling. Ann N Y Acad Sci 2010; 1024: 38-59. [DOI:10.1111/j.1749-6632.2010.05568.x] [PMID] [PMCID]

9. [9] Fava M, Hwang I, Rush AJ, Sampson N, Walters EE, Kessler RC. The importance of irritability as a symptom of major depressive disorder: results from the National Comorbidity Survey Replication. Mol Psychiatry 2010; 15: 856-867. [DOI:10.1038/mp.2009.20] [PMID] [PMCID]

10. [10] McLean CP, Asnaani A, Litz BT, Hofmann SG. Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness. J Psychiatric Res 2011; 45: 1027-1035. [DOI:10.1016/j.jpsychires.2011.03.006] [PMID] [PMCID]

11. [11] Fox AS, Shackman AJ. The central extended amygdala in fear and anxiety: Closing the gap between mechanistic and neuroimaging research. Neurosci Lett 2019; 693: 58-67. [DOI:10.1016/j.neulet.2017.11.056] [PMID] [PMCID]

12. [12] Blume SR, Padival M, Urban JH, Rosenkranz JA. Disruptive effects of repeated stress on basolateral amygdala neurons and fear behavior across the estrous cycle in rats. Sci Rep 2019; 9: 12292. [DOI:10.1038/s41598-019-48683-3] [PMID] [PMCID]

13. [13] Zhang X, Tong Tong Ge, Yin G, Cui R, Zhao G, Yang W. Stress-Induced functional alterations in amygdala: implications for neuropsychiatric diseases. Front Neurosci 2018; 12: 367. [DOI:10.3389/fnins.2018.00367] [PMID] [PMCID]

14. [14] Yang Y, Wang JZ. From structure to behavior in basolateral amygdala-hippocampus circuits. Front Neural Circuits 2017; 11: 86. [DOI:10.3389/fncir.2017.00086] [PMID] [PMCID]

15. [15] Faraji N, Shiravi A, Bahari Z, Shirvani H, Meftahi GH. Basolateral amygdala α1-Adrenergic receptor suppression attenuates stress-induced anxiety-like behavior and spine morphology impairment on hippocampal CA1 pyramidal neurons. Neurochem J 2020; 14: 77-89. [DOI:10.1134/S1819712420010079]

16. [16] Aubry AV, Serrano PA, Burghardt NS. Molecular mechanisms of stress-induced increases in fear memory consolidation within the amygdala. Front Behav Neurosci 2016; 10: 191. [DOI:10.3389/fnbeh.2016.00191] [PMID] [PMCID]

17. [17] Onur OA, Walter H, Schlaepfer TE, Rehme AK, Schmidt C, Keysers C, et al. Noradrenergic enhancement of amygdala responses to fear. Soc Cogn Affect Neurosci 2009; 4: 119-126. [DOI:10.1093/scan/nsn049] [PMID] [PMCID]

18. [18] McCall JG, Siuda ER, Bhatti DL, Lawson LA, McElligott ZA, Stuber GD, et al. Locus coeruleus to basolateral amygdala noradrenergic projections promote anxiety-like behavior. Life 2017; 6: e18247. [DOI:10.7554/eLife.18247] [PMID] [PMCID]

19. [19] Buffalari DM, Grace AA. Noradrenergic modulation of basolateral amygdala neuronal activity: opposing influences of α-2 and β receptor activation. J Neuroscience 2007; 27: 12358-12366. [DOI:10.1523/JNEUROSCI.2007-07.2007] [PMID] [PMCID]

20. [20] Kang EH, Yu BH. Anxiety and β-adrenergic receptor function in a normal population. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 733-737 [DOI:10.1016/j.pnpbp.2005.04.027] [PMID] [PMCID]

21. [22] LeDoux J. The emotional brain, fear, and the amygdala. Cell Mol Neurobiol 2003; 23: 727-738. [DOI:10.1023/A:1025048802629] [PMID]

22. [23] Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 2007; Elsevier: Academic Press (6th Edition).

23. [24] Dalooei JR, Sahraei H, Meftahi GH, Khosravi M, Bahari Z, Hatef B, et al. Temporary amygdala inhibition reduces stress effects in female mice. J Adv Res 2016; 7: 643-649. [DOI:10.1016/j.jare.2016.06.008] [PMID] [PMCID]

24. [25] Albrechet-Souza L, Cristina de Carvalho M, Rodrigues Franci C, Brandao ML. Increases in plasma corticosterone and stretched-attend postures in rats naive and previously exposed to the elevated plus-maze are sensitive to the anxiolytic-like effects of midazolam. Horm Behav 2007; 52: 267-273. [DOI:10.1016/j.yhbeh.2007.05.002] [PMID]

25. [26] Carola V, D'Olimpio F, Brunamonti E, Mangia F, Renzi P. Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice. Behav Brain Res 2002; 134: 49-57. [DOI:10.1016/S0166-4328(01)00452-1]

26. [27] Calfa G, Volosin M, Molina VA. Glucocorticoid receptors in lateral septum are involved in the modulation of the emotional sequelae induced by social defeat. Behav Brain Res 2006; 172: 324-332. [DOI:10.1016/j.bbr.2006.05.022] [PMID]

27. [28] Bignante EA, Paglini G, Molina VA. Previous stress exposure enhances both anxiety-like behaviour and p35 levels in the basolateral amygdala complex: modulation by midazolam. Eur Neuropsychopharmacol 2010; 20: 388-397. [DOI:10.1016/j.euroneuro.2010.02.007] [PMID]

28. [29] Bali A, Jaggi AS. Electric foot shock stress: a useful tool in neuropsychiatric studies. Rev Neurosci 2015; 26: 655-677. [DOI:10.1515/revneuro-2015-0015] [PMID]

29. [30] Yamaguchi T, Tsujimatsu A, Kumamoto H, Izumi T, Ohmura Y, Yoshida T, et al. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress. J Ethnopharmacol 2012; 143: 533-539. [DOI:10.1016/j.jep.2012.07.007] [PMID]

30. [31] Guedri K, Frih H, Chettoum A, Rouabhi R. Chronic restraint stress induced neurobehavioral alterations and histological changes in rat. J Toxicol Environ Health Sci 2017; 9: 123-129. [DOI:10.1007/s13530-017-0312-6]

31. [32] Miller DB, O'Callaghan JP. Neuroendocrine aspects of the response to stress. Metabolism 2002; 51: 5-10. [DOI:10.1053/meta.2002.33184] [PMID]

32. [33] Fu A, Li X, Zhao B. Role of beta1-adrenoceptor in the basolateral amygdala of rats with anxiety-like behavior. Brain Res 2008; 1211: 85-92. [DOI:10.1016/j.brainres.2008.03.013] [PMID]

33. [34] Rauch SL, Whalen PJ, Shin LM, McInerney SC, Macklin ML, Lasko NB, et al. Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study. Biol Psychiatry 2000; 47: 769-776. [DOI:10.1016/S0006-3223(00)00828-3]

34. [35] Stein MB, Simmons AN, Feinstein JS, Paulus MP. Increased amygdala and insula activation during emotion processing in anxiety-prone subjects. Am J Psychiatry 2007; 164: 318-327. [DOI:10.1176/ajp.2007.164.2.318] [PMID]

35. [36] Valizadegan F, Oryan S, Nasehi M, Zarrindast MR. Interaction between morphine and noradrenergic system of basolateral amygdala on anxiety and memory in the elevated plus-maze test based on a test-retest paradigm. Arch Iran Med 2013; 16: 281-287.

36. [37] Buffalari DM, Grace AA. Anxiogenic modulation of spontaneous and evoked neuronal activity in the basolateral amygdala. Neuroscience 2009; 163: 1069-1077. [DOI:10.1016/j.neuroscience.2009.07.003] [PMID] [PMCID]

37. [38] Hurlemann R, Walter H, Rehme AK, Kukolja J, Santoro SC, Schmidt C, et al. Human amygdala reactivity is diminished by the β-noradrenergic antagonist propranolol. Psychol Medicine 2010; 40: 1839-1848. [DOI:10.1017/S0033291709992376] [PMID]